Extracellular signal-regulated kinase mediates granulocyte-macrophage colony-stimulating factor messenger RNA stabilization in tumor necrosis factor-α plus fibronectin-activated peripheral blood eosinophils

Blood

Volumn 99, Issue 11, 2002, Pages 4048-4052

  Esnault, Stéphane ^a   Malter, James S ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FIBRONECTIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; INTERLEUKIN 3; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EOSINOPHIL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; RNA ANALYSIS; RNA STABILITY;

EID: 0036624718     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.11.4048     Document Type: Article

References (45)

1. Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med. 1990;323:1033-1039.
2. Esnault S, Malter JS. Granulocyte macrophagecolony-stimulating factor mRNA is stabilized in airway eosinophils and peripheral blood eosinophils activated by TNF-alpha plus fibronectin. J Immunol. 2001;166:4658-4663.
3. Kim JT, Gleich GJ, Kita H. Roles of CD9 molecules in survival and activation of human eosinophils. J Immunol. 1997;159:926-933.
4. Kim JT, Schimming AW, Kita H. Ligation of Fc-γRII (CD32) pivotally regulates survival of human eosinophils. J Immunol. 1999;162:4253-4259.
5. Meerschaert J, Vrtis RF, Shikama Y, Sedgwick JB, Busse WW, Mosher DF. Engagement of α4β7 integrins by monoclonal antibodies or ligands enhances survival of human eosinophils in vitro. J Immunol. 1999;163:6217-6227.
6. Levi-Schaffer F, Temkin V, Malamud V, Feld S, Zilberman Y. Mast cells enhance eosinophil survival in vitro: Role of TNF-α and granulocyte-macrophage colony-stimulating factor. J Immunol. 1998;160:5554-5562.
7. Alon R, Cahalon L, Hershkovfc R, et al. TNF-α binds to the N-terminal domain of fibronectin and augments the β1-integrin-mediated adhesion of CDA+ T lymphocytes to the glycoprotein. J Immunol. 1994;152:1304-1313.
8. Franita S, Hershokoviz R, Kam N, et al. TNF-α associated with extracellular matrix fibronectin provides a stop signal for chemotactically migrating T cells. J Immunol. 2000;165:2738-2747.
9. Capowski EE, Esnault S, Bhattacharya S, Malter JS. Y Box binding factor promotes eosinophil survival by stabilizing GM-CSF mRNA. J Immunol. 2001;167:5970-5976.
10. Chen C-Y, Del Gatto-Konczak F, Wu Z, Karin M. Stabilization of interleukin-2 mRNA by the c-Jun NH2-terminal kinase pathway. Science. 1998;280:1945-1949.
11. Ming X-F, Kaiser M, Moroni C. c-jun N-terminal kinase is involved in AUUUA-mediated interleukin-3 mRNA turnover in mast cells. EMBO J. 1998;17:6039-6048.
12. Esnault S, Malter JS. Primary peripheral blood eosinophils rapidly degrade transfected granulocyte-macrophage colony-stimulating factor mRNA. J Immunol. 1999;163:5228-5234.
13. Bates ME, Green VL, Bertics PJ. Erk1 and Erk2 activation by chemotactic factors in human eosinophils is interleukin 5-dependent and contributes to leukotriene C4 biosynthesis. J Biol Chem. 2000;275:10968-10975.
14. Rajagopalan LE, Burkholder JK, Turner J, Culp J, Yang NS, Malter JS. Granulocyte-macrophage colony-stimulating factor mRNA stabilization enhances transgenic expression in normal cells and tissues. Blood. 1995;86:2551-2558.
15. Reunanen N, Foschi M, Han J, Kähäri V-M. Activation of extracellular signal-regulated kinase 1/2 inhibits type I collagen expression by human skin fibroblasts. J Biol Chem. 2000;275:34634-34639.
16. Brauchle M, Gluck D, Di Padova F, Han J, Gram H. Independent role of p38 and ERK1/2 mitogen-activated kinases in the upregulation of matrix metalloproteinase-1. Exp. Cell Res. 2000;258:135-144.
17. Hall DJ, Cui J, Bates ME, et al. Transduction of a dominant-negative H-Ras into human eosinophils attenuates extracellular signal-regulated kinase activation and interleukin-5-mediated cell viability. Blood. 2001;98:2014-2001.
18. Vocero-Akbani A, Lissy NA, Dowdy SF. Transduction of full-length tat fusion proteins directly into mammalian cells: Analysis of T cell receptor activation-induced cell death. Methods Enzymol. 2000;322:508-521.
19. Esnault S, Malter JS. Minute quantities of GM-CSF prolong eosinophil survival. J Interferon Cytokine Res. 2001;21:117-124.
20. Kampen GT, Stafford S, Adachi T, et al. Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases. Blood. 2000;95:1911-1917.
21. Tsukahara K, Nakao A, Hiraguri M, et al. Tumor necrosis factor-a mediates antiapoptotic signals partially via p38 MAPKinase activation in human eosinophils. Int Arch Allergy Immunol. 1999;120(suppl 1):54-59.
22. Sano H, Zhu X, Sano A, et al. Extracellular signal-regulated kinase 1/2-mediated phosphorylation of cytosolic phospholipase A2 is essential for human eosinophil adhesion to fibronectin. J Immunol. 2001;166:3515-3521.
23. Ni H, Wang XS, Diener K, Yao Z. MAPKAPK5, a novel mitogen-activated protein kinase (MAPK)-activated kinase, is a substrate of extracellular-regulated kinase (ERK) and p38. Biochem Biophys Res Commun. 1998;243:492-496.
24. Ludwig S, Engel K, Hoffmeyer A, et al. 3pK, a novel mitogen-activated protein (MAP) kinase-activated protein kinase, is targeted by three MAP kinase pathways. Mol Cell Biol. 1996;12:6687-6697.
25. Tanoue T, Maeda R,Adachi M, Nishida E. Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions. EMBO J. 2001;20:466-479.
26. Fukunaga R, Hunter T. MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J. 1997;16:1921-1933.
27. Ludwig S, Hoffmeyer A, Goebeler M, et al. The stress inducer arsenite activates mitogen-activated protein kinases extracellular signalregulated kinases 1 and 2 via a MAPK kinase 6/p38-dependent pathway. J Biol Chem. 1998;273:1917-1922.
28. Miyazawa K, Mori A, Miyata H, Akahane M, Ajisawa Y, Okudaira H. Regulation of interleukin-1b-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen-activated protein kinase. J Biol Chem. 1998;273:24832-24838.
29. Ridley HS, Dean JLE, Sarsfield SJ, Brook M, Clark AR, Saklatvala J. A p38 MAP kinase inhibitor regulates stability of intedeukin-1-induced cyclooxygenase-2 mRNA. FEBS Lett. 1998;439:75-80.
30. Winzen R, Kracht M, Ritter B, et al. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J. 1999;18:4969-4980.
31. Rutault K, Hazzalin CA, Mahadevan LC. Combinations of ERK and p38 MAPK inhibitors ablate tumor necrosis factor-a (TNF-a) mRNA induction. J Biol Chem. 2001;276:6666-6674.
32. Lasa M, Brook M, Saklatvala J, ClarkAR. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38. Mol Cell Biol. 2001;21:771-780.
33. Xiao Y-Q, Someya K-I, Morita H, Takahashi K, Ohuchi K. Involvement of p38 MAPK and ERK/MAPK pathways in staurosporine-induced production of macrophage inflammatory protein-2 in rat peritoneal neutrophils. Biochim Biophys Acta. 1999;1450:155-163.
34. Westmark CJ, Malter JS. Up-regulation of nucleolin mRNA and protein in peripheral blood mononuclear cells by extracellular-regulated kinase. J Biol Chem. 2001;276:1119-1126.
35. Westmark CJ, Malter JS. Extracellular-regulated kinase controls beta-amyloid precursor protein mRNA decay. Brain Res Mol Brain Res. 2001;90:193-201.
36. Adachi T, Choudhury BK, Stafford S, Sur S, Alam R. The differential role of extracellular signal-regulated kinases and p38 mitogen-activated protein kinase in eosinophil functions. J Immunol. 2000;165:2198-2204.
37. Bates ME, Bertics PJ, Busse WW. IL-5 activates a 45-kilodalton mitogen-activated protein (MAP) kinase and Jak-2 tyrosine kinase in human eosinophils. J Immunol. 1996;156:711-718.
38. Lindsay MA, Haddad E-B, Rousell J, et al. Role of the mitogen-activated protein kinase and tyrosine kinases during leukotriene B4-induced eosinophil activation. J Leukoc Biol. 1998;64:555-562.
39. Sullivan SK, McGrath DA, Liao F, Boehme SA, Farber JM, Bacon KB. MIP-3α induces human eosinophil migration and activation of the mitogen-activated protein kinases (p42/p44 MAPK). J Leukoc Biol. 1999;66:674-682.
40. Santala P, Heino J. Regulation of integrin-type cell adhesion receptors by cytokines. J Biol Chem. 1991;266:23505-23509.
41. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science. 1999;286:1358-1362.
42. Simon H-U, Yousefi S, Dibbert B, Levi-Schaffer F, Blaser K. Anti-apoptotic signals of granulocyte-macrophage colony-stimulating factor are transduced via Jak2 tyrosine kinase in eosinophils. Eur J Immunol. 1997;27:3536-3539.
43. Coffer PJ, Schweizer RC, Dubois GR, et al. Analysis of signal transduction pathway in human eosinophils activated by chemoattractants and the T-helper 2-derived cytokines interleukin-4 and interleukin-5. Blood. 1998;91:2547-2557.
44. Fan XC, Steitz JA. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J. 1998;17:3448-3460.
45. Chen C-Y, Gherzi R, Anderson JS, et al. Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation. Genes Dev. 2000;14:1236-1248.